Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006326 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
A NA study, sponsored by Agouron Pharmaceuticals.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00006326 is a NA study that was terminated before completion, run by Agouron Pharmaceuticals. The registered enrollment target is 60 participants.
The verdict
NCT00006326, a NA study, was terminated before completion, sponsored by Agouron Pharmaceuticals.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to see if 3 anti-HIV drug combinations are safe and effective in patients who have failed previous anti-HIV treatments using nelfinavir (NFV).
Interventions
- DRUG Ritonavir
- DRUG Indinavir sulfate
- DRUG Delavirdine mesylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2000-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006326
The ClinicalTrials.gov registry entry for NCT00006326 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agouron Pharmaceuticals, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ritonavir is the first listed.
NCT00006326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006326 about?
NCT00006326 is a clinical study titled "Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir". The purpose of this study is to see if 3 anti-HIV drug combinations are safe and effective in patients who have failed previous anti-HIV treatments using nelfinavir (NFV).
What is the current status of trial NCT00006326?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2000-08.
What interventions are being tested in trial NCT00006326?
The interventions under investigation include: Ritonavir (DRUG), Indinavir sulfate (DRUG), Delavirdine mesylate (DRUG).
Who is sponsoring clinical trial NCT00006326?
This trial is sponsored by Agouron Pharmaceuticals, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.